Vimarsana
Biggest News Aggregation in the World

4568 To News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 4568 To. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 4568 To Today - Breaking & Trending Today

Esperion Therapeutics, Daiichi Sankyo Europe Reach $125M Payment Agreement Over Commercial Litigation - Vimarsana News

Esperion Therapeutics, Daiichi Sankyo Europe Reach $125M Payment Agreement Over Commercial Litigation

By Sabela Ojea Esperion Therapeutics and Daiichi Sankyo Europe GmbH said they have settled their pending commercial litigation and agreed on a $125 million...

Merck's Earnings Are Thursday. Here's What to Expect. - Vimarsana News

Merck's Earnings Are Thursday. Here's What to Expect.

Pharmaceutical stocks have generally fallen, partly because of regulatory concerns, but also because high interest rates have made the companies dividends...

New Zealand Shares Lose 0.8% for Biggest Decline in Four Weeks - Vimarsana News

New Zealand Shares Lose 0.8% for Biggest Decline in Four Weeks

Nestle’s real internal growth in the third quarter showed a sequential underlying improvement in volume trends, Citi said, adding the RIG consensus miss was small, and “should leave 2023 consensus expectations pretty much unchanged.”

Source: wsj.com
AstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EU - Vimarsana News

AstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EU

By Christian Moess Laursen AstraZeneca said its lung-cancer drug Enhertu has been recommended for approval in the European Union following positive test...

AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates - Vimarsana News

AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates

By Anthony O. Goriainoff AstraZeneca and Daiichi Sankyo said that datopotamab deruxtecan, a cancer drug, combined with the Imfinzi cancer treatment--with or...